Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice
X-linked myotubular myopathy is caused by mutations in the gene coding for myotubularin 1, and is characterized by overexpression of dynamin 2. Here the authors develop antisense oligonucleotides to dynamin 2, and show that systemic injection leads to improved pathology in mice.
Guardado en:
Autores principales: | Hichem Tasfaout, Suzie Buono, Shuling Guo, Christine Kretz, Nadia Messaddeq, Sheri Booten, Sarah Greenlee, Brett P. Monia, Belinda S. Cowling, Jocelyn Laporte |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ea5ef61a87bf47839d28720d6a64f759 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances
por: Raquel Gómez-Oca, et al.
Publicado: (2021) -
Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy
por: Elinam Gayi, et al.
Publicado: (2018) -
Tamoxifen therapy in a murine model of myotubular myopathy
por: Nika Maani, et al.
Publicado: (2018) -
Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy
por: Niels Grote Beverborg, et al.
Publicado: (2021) -
Tritium labeling of antisense oligonucleotides via different conjugation agents
por: Martin R. Edelmann, et al.
Publicado: (2021)